SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 155 filers reported holding SERES THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $462,393 | -49.0% | 194,332 | +2.7% | 0.00% | -50.0% |
Q2 2023 | $906,056 | +15238.7% | 189,181 | +18055.6% | 0.00% | – |
Q1 2023 | $5,907 | -15.6% | 1,042 | -22.4% | 0.00% | – |
Q4 2022 | $7,000 | -75.9% | 1,342 | -70.7% | 0.00% | – |
Q3 2022 | $29,000 | +866.7% | 4,583 | +339.8% | 0.00% | – |
Q2 2022 | $3,000 | -57.1% | 1,042 | +5.0% | 0.00% | – |
Q1 2022 | $7,000 | -30.0% | 992 | -16.8% | 0.00% | – |
Q4 2021 | $10,000 | +42.9% | 1,192 | +20.5% | 0.00% | – |
Q3 2021 | $7,000 | -81.6% | 989 | -37.3% | 0.00% | – |
Q2 2021 | $38,000 | +18.8% | 1,577 | +1.0% | 0.00% | – |
Q1 2021 | $32,000 | +88.2% | 1,561 | +116.2% | 0.00% | – |
Q4 2020 | $17,000 | -29.2% | 722 | -16.9% | 0.00% | – |
Q3 2020 | $24,000 | -52.9% | 869 | -91.8% | 0.00% | – |
Q2 2020 | $51,000 | +34.2% | 10,600 | 0.0% | 0.00% | – |
Q1 2020 | $38,000 | – | 10,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
Knott David M Jr | 470,000 | $2,251 | 0.90% |
GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |